Assoc. Prof. Dr. Mehmet Salih İyikesici

Education MEHMET SALİH İYİKESİCİ ALTINBAŞ UNIVERSITY HEALTH SCIENCES MEDICAL ONCOLOGY MARMARA UNIVERSITY Subspecialty in Medicine July 14, 2006 FACULTY OF MEDICINE/DEPARTMENT OF INTERNAL MEDICINE/DEPARTMENT OF INTERNAL MEDICINE/ONCOLOGY Thesis title: Relationship between HER-2/neu expression and pAkt, pMAPK and topo II alpha expressions in breast cancer (2006) OTHER (INSTITUTIONS, HOSPITALS ETC.) Medical Specialization August 1, 1996 1992 HOSPITALS/ISTANBUL HAYDARPAŞA NUMBER TRAINING AND RESEARCH HOSPITAL Thesis title: Hemolytic anemias due to mechanical trauma in patients with A-v fistula (1996) Thesis Advisor: (Aydoğan Albayrak) Bachelor's Degree August 1, 1990 Languages English ULUDAĞ UNIVERSITY 1985 FACULTY OF MEDICINE/MEDICINE PR. 13.03.2022, YÖKDİL, Score: 61.25 Academic Duties DOCTOR LECTURER 2014 Memberships in Scientific Organizations ALTINBAŞ UNIVERSITY/FACULTY OF MEDICINE/DEPARTMENT OF INTERNAL MEDICAL SCIENCES/DEPARTMENT OF INTERNAL DISEASES) 1. MEDICAL ONCOLOGY ASSOCIATION, Member, 2004 Page:1Articles : M-628-9396 İYİKESİCİ MEHMET SALİH (2020). Preliminary results of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in stage II-IV rectal cancer. Archives of Clinical and Experimental Medicine, 5(1), 16-20. M-159-5689 YUMUK PERRAN FULDEN,İYİKESİCİ M EHMET SAL İH,GÜMÜŞ M AHMUT, ALİUSTAOĞLU MEHMET,DANE FAYSAL,BAŞARAN GÜL,EKENEL MELTEM,ABACIOĞLU UFUK,TURHAL NAZIM SERDAR (2004). Lokal İleri ve Metastatik Küçük Hücreli Dışı Akciğer Kanseri Hastalarının Değerlendirilmesi Marmara Üniversitesi Deneyimi. Türk Onkoloji Dergisi, 19(3) M-159-3931 BAŞARAN GÜL,EKENEL MELTEM,DEMİRKALEM PAKİZE,ÇAKIR TEBESSÜM,GÜLLÜOĞLU MAHMUT BAHADIR,GÜMÜŞ MAHMUT,DANE FAYSAL,İYİKESİCİ MEHMET SALİH,KAYA HANDAN,YUMUK PERRAN FULDEN,TURHAL NAZIM SERDAR (2004). Evre I T1N0M0 Meme Kanseri Patolojik Özellikler ve Klinik Sonuçlar. Türk Onkoloji Dergisi, 19(2) International M-722-6243 İYİKESİCİ MEHMET SALİH, Slocum Abdul Kadir, Winters Nasha, Kalamian Miriam, Seyfried Thomas N. (2021). Metabolically Supported Chemotherapy for Managing End-Stage Breast Cancer: A Complete and Durable Response. Cureus, 13(4), 14686, Doi: 10.7759/cureus.14686 (Çeyreklik Dilim=Q3) M-628-9358 Seyfried Thomas N.,Mukherjee Purna,İYİKESİCİ MEHMET SALİH,Slocum Abdul Kadir,Kalamian Miriam,Spinosa Jean-Pierre,Chinopoulos Christos (2020). Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer NUTRITION, 7, Doi: 10.3389/fnut.2020.00021 (Çeyreklik Dilim=Q1) . FRONTIERS IN M-628-9370 İYİKESİCİ MEHMET SALİH (2020). Survival outcomes of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in advanced gastric cancer. NIGERIAN JOURNAL 10.4103/njcp.njcp_509_18 OF (Çeyreklik CLINICAL Dilim=Q4) PRACTICE, 23(5), 734-740., Doi: M-628-9364 İYİKESİCİ MEHMET SALİH (2020). Long-Term Survival Outcomes of Metabolically Supported Chemotherapy with Gemcitabine-Based or FOLFIRINOX Regimen Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy in Metastatic Pancreatic Cancer . COMPLEMENTARY MEDICINE RESEARCH, 27(1), 31-39., Doi: 10.1159/000502135 (Çeyreklik Dilim=Q4) M-628-9355 İYİKESİCİ MEHMET SALİH (2019). Feasibility study of metabolically supported chemotherapy with weekly carboplatin/paclitaxel combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in metastatic non-small cell lung cancer. International Journal of Hyperthermia, 36(1), 446-455., Doi: 10.1080/02656736.2019.1589584 (Çeyreklik Dilim=Q2) M-629-8844 İYİKESİCİ MEHMET SALİH,Slocum Abdul Kadir,Slocum Ayshe,Berkarda Ferhan Bülent,Kalamian Miriam,Seyfried Thomas N (2017). Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer. Cureus, 9(7) (Çeyreklik Dilim=Q3) M-628-9295 İYİKESİCİ MEHMET SALİH,Slocum Ayshe,TÜRKMEN ENGİN,AKDEMİR ÖVÜNÇ,Slocum Abdul Kadir,İPEK TURGUT,EYÜBOĞLU MUSTAFA ERHUN,Berkarda Ferhan Bülent (2016). Long-Term Outcomes of the Treatment of Unresectable (StageIII- IV) Ductal Pancreatic Adenocarcinoma Using Metabolically Supported Chemotherapy (MSCT): A Retrospective Study. Journal of the Pancreas, 17(1), 36-41. M-628-9380 İYİKESİCİ MEHMET SALİH,Slocum Ayşe,TÜRKMEN ENGİN,AKDEMİR ÖVÜNÇ,Slocum Abdul Kadir,Berkarda Ferhan Bülent (2016). Complete Response of Locally Advanced (stage III) Rectal Cancer to Metabolically Supported Chemoradiotherapy with Hyperthermia . International Journal of Cancer Research and Molecular Mechanisms ( ISSN 2381-3318 ), 2(1) M-158-7461 İYİKESİCİ MEHMET SALİH,BAŞARAN GÜL,DANE FAYSAL,EKENEL MELTEM,YUMUK PERRAN FULDEN,ÇABUK DEVRİM,Teomete Mehmet,TURHAL NAZIM SERDAR (2014). Associations between clinicopathological prognostic factors and pAkt pMAPK and topoisomerase II expression in breast cancer. International Journal of Clinical and Experimental Medicine, 7(5), 1459-1464. (Çeyreklik Dilim=Q4) M-158-7559 KEFELİ UMUT,DANE FAYSAL,YUMUK PERRAN FULDEN,YAVUZ KARAMANOĞLU AYLA,İYİKESİCİ MEHMET SALİH,BAŞARAN GÜL,TURHAL NAZIM SERDAR (2009). Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer. European Journal of Cancer Care, 18(2), 191-194., Doi: 10.1111/j.1365-2354.2008.00973.x (Çeyreklik Dilim=Q3) M-158-8848 YUMUK PERRAN FULDEN,DANE FAYSAL,YUMUK VOLKAN DEMİRHAN,YAZICI DİLEK,Ege Bahadır,BEKİROĞLU GÜLNAZ NURAL,TOPRAK AHMET,İYİKESİCİ MEHMET SALİH,BAŞARAN GÜL,TURHAL NAZIM SERDAR (2008). Impact of body mass index on cancer development. Journal of the Balkan Union of Oncology, 13(1), 55-59. M-159-3739 ÇABUK DEVRİM,BAŞARAN GÜL,ÇELİKEL ÇİĞDEM,DANE FAYSAL,YUMUK PERRAN FULDEN,İYİKESİCİ MEHMET SALİH,EKENEL MELTEM,TURHAL NAZIM SERDAR (2007). Vascular Page: 2 Articles : Posters National Growth Factor, Hypoxia-Inducible Factor 1 Alpha and CD34 Expressions in Early-Stage Gastric Tumors: Relationship with Pathological Factors and Prognostic Impact on Survival . Oncology, 72, 111-117., Doi: 10.1159/000111118 (Çeyreklik Dilim=Q3) B-763-7518 BRCA1/2 moleküler tanısında likit biyopsinin önemi: Vaka sunumu , BOGA İBRAHİM, İYİKESİCİ MEHMET SALİH, BİŞGİN ATIL (2019).. Ulusal Kanser Kongresi, (Özet bildiri) B-763-7539 B-161-0584 Hepatoselüler Karsinomada Likit Biyopsi: Yeni Nesil Dizileme Aracılı Genomik Profilleme , BİŞGİN ATIL, MÜJDE CEM, İYİKESİCİ MEHMET SALİH, BOGA İBRAHİM (2019).. Çukurova Hepatoselüler Karsinoma Kongresi, (Özet bildiri) Evre 4 pankreas adenokarsinomu tedavisinde metabolik destekli kemoterapi MDKT uygulamasının sağkalım üzerine etkisi , İYİKESİCİ MEHMET SALİH,SLOCUM AYSHE,TÜRKMEN ENGİN,AKDEMİR ÖVÜNÇ,SLOCUM ABDUL KADIR,BERKARDA FERHAN BÜLENT (2015).. 12. TÜRK HEPATOPANKREATOBİLİER CERRAHİ KONGRESİ, (Özet bildiri) B-160-9688 TÜRK TOPLUMUNDA REKTUM KANSERLI HASTALARIN DEMOGRAFIK HISTOPATOLOJIK OZELLIKLERI SAĞ KALIM VE PROGNOSTIK FAKTÖRLER , DANE FAYSAL,GÜMÜŞ MAHMUT,YAMAN EMEL,ÖZTÜRK MEHMET AKİF,SEVİNÇ ALPER,ATASOY BESTE MELEK,ÇABUK DEVRİM,İYİKESİCİ MEHMET SALİH,YUMUK PERRAN FULDEN,BAŞARAN GÜL,ABACIOĞLU UFUK,TEOMETE MEHMET,TURHAL NAZIM SERDAR (2008).. 5. ULUSAL TIBBİ ONKOLOJİ KONGRESİ, (Özet bildiri) B-160-9805 ADJUVAN KEMORADYOTERAPİ VERİLEN EVRE II III REKTUM KANSERİ HASTALARININ SAĞKALIM VE PROGNOSTİK AÇIDAN DEĞERLENDİRİLMESİ , DANE FAYSAL,GÜMÜŞ MAHMUT,İYİKESİCİ MEHMET SALİH,YUMUK PERRAN FULDEN,BAŞARAN GÜL,ATASOY BESTE MELEK,ABACIOĞLU UFUK,NAZIM SERDAR TURHAL (2006).. 1. TIBBİ ONKOLOJİ KONGRESİ, (Özet bildiri) B-160-9774 PALYATİF KEMOTERAPİ ALAN METASTATİK KOLOREKTAL KANSER HASTALARININ SAĞKALIM SONUÇLARI , DANE FAYSAL,YUMUK PERRAN FULDEN,İYİKESİCİ MEHMET SALİH,GÜMÜŞ MAHMUT,TUFAN ÇİNÇİN ASLI,BAŞARAN GÜL,TEOMETE MEHMET,TURHAL NAZIM SERDAR (2006).. 1. TIBBİ ONKOLOJİ KONGRESİ, (Özet bildiri) B-160-9727 ADJUVAN KEMOTERAPİ ALAN KOLON KANSERİ HASTALARININ SAĞKALIM VE PROGNOSTİK AÇIDAN DEĞERLENDİRİLMESİ , DANE FAYSAL,GÜMÜŞ MAHMUT,İYİKESİCİ MEHMET SALİH,YUMUK PERRAN FULDEN,ÖZTÜRK MEHMET AKİF,BAŞARAN GÜL,ÇABUK DEVRİM,TURHAL NAZIM SERDAR (2006).. 1. TIBBİ ONKOLOJİ KONGRESİ, (Özet bildiri) B-161-0005 KNOXVİLLE TENNESSEE USA DE EVRE III VE IV KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERLİ HASTALARIN SONUÇLARI , TURHAL NAZIM SERDAR,YUMUK PERRAN FULDEN,İYİKESİCİ MEHMET SALİH,DANE FAYSAL,BAŞARAN GÜL,EKENEL MELTEM,AVERY BRUCE (2005).. XVI. ULUSAL KANSER KONGRESİ, (Özet bildiri) B-160-9946 MARMARA ÜNİVERSİTESİ HASTANESİNDEKİ EVRE III VE IV KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERİ HASTALARIN SONUÇLARI , İYİKESİCİ MEHMET SALİH,YUMUK PERRAN FULDEN,DANE FAYSAL,BAŞARAN GÜL,EKENEL MELTEM,ABACIOĞLU UFUK,ŞENGÖZ KAZIM MERİÇ,TURHAL NAZIM SERDAR (2005).. XVI. ULUSAL KANSER KONGRESİ, (Özet bildiri) B-160-9881 MEME KANSERİ HASTALARINDA HPV DNA AMPLİFİKASYONU VE P53 EKSPRESYONUNUN PROGNOSTİK DEĞERİ , YUMUK PERRAN FULDEN,GÜMÜŞ MAHMUT,DANE FAYSAL,KAYA HANDAN,ALAM KÜRŞAT,İYİKESİCİ MEHMET SALİH,GÜLLÜOĞLU MAHMUT BAHADIR,EKENEL MELTEM,BAŞARAN GÜL,TURHAL NAZIM SERDAR (2005).. XVI. ULUSAL KANSER KONGRESİ, (Özet B-161-0169 KEMOTERAPİ VERİLEN LOKAL İLERİ VE METASTATİK KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERİ HASTALARININ SAĞKALIM VE PROGNOSTİK AÇIDAN DEĞERLENDİRİLMESİ , YUMUK PERRAN FULDEN,İYİKESİCİ M EHM ET SA LİH,GÜMÜŞ M AHM UT, ALİ USTAOĞLU MEHMET,DANE FAYSAL,BAŞARAN GÜL,EKENEL MELTEM,ABACIOĞLU UFUK,TURHAL NAZIM SERDAR (2004).. 1. Ulusal Torasik Onkoloji Kongresi, (Özet bildiri) International B-765-4796 Insulin Potentiation Therapy-High Dose Hospital Administration. Protocol Description and Clinical Results , Berkarda Bülent, İYİKESİCİ MEHMET SALİH (2014).. 2014 Annual Global Conference on IPT, (Özet bildiri) B-159-6254 DEMOGRAPHICAL SURVIVAL AND PROGNOSTIC FEATURES OF RESECTED RECTAL CANCER IN TURKISH PATIENTS POPULATION , DANE FAYSAL,GÜMÜŞ MAHMUT,YAMAN EMEL,ÖZTÜRK MEHMET AKİF,SEVİNÇ ALPER,ATASOY BESTE MELEK,ÇABUK DEVRİM,İYİKESİCİ MEHMET SALİH,YUMUK PERRAN FULDEN,BAŞARAN GÜL,ABACIOĞLU UFUK,TEOMETE MEHMET,TURHAL NAZIM SERDAR (2008).. 18th International Postgraduate Course of the International Association of Surgeons, Gastroenterologists,Oncologists, 55(Ref No:1190), (Özet bildiri) Page: 3 B-159-6474 Clinical features and outcome of adjuvant chemoradiotherapy in Turkish rectal carcinoma patients Single institution experience , DANE FAYSAL,GÜMÜŞ MAHMUT,ÖZTÜRK MEHMET AKİF,ÇABUK DEVRİM,ATASOY BESTE MELEK,YUMUK PERRAN FULDEN,BAŞARAN GÜL,İYİKESİCİ MEHMET SALİH,TEOMETE MEHMET,ABACIOĞLU UFUK,TURHAL NAZIM SERDAR (2008).. 2008 American Society of Clinical Oncology Annual Meeting, 26(15S Part: I of II), (Özet bildiri) B-159-6502 Outcome of metastatic colorectal cancer patients receiving second line chemotherapy in Marmara University Hospital , DANE FAYSAL,GÜMÜŞ MAHMUT,ÖZTÜRK MEHMET AKİF,YUMUK PERRAN FULDEN,İYİKESİCİ MEHMET SALİH,BAŞARAN GÜL,ÇABUK DEVRİM,TEOMETE MEHMET,TURHAL NAZIM SERDAR (2007).. 2007 American Society of Clinical Oncology Annual Meeting, 25(18S Part I of II), (Özet bildiri) B-159-6346 Clinical outcome of node negative NN breast cancer BC patients , BAŞARAN GÜL,ÇABUK DEVRİM,DANE FAYSAL,TEOMETE MEHMET,İYİKESİCİ MEHMET SALİH,EKENEL MELTEM,GÜLLÜOĞLU MAHMUT BAHADIR,KAYA HANDAN,ABACIOĞLU UFUK,YUMUK PERRAN FULDEN,TURHAL NAZIM SERDAR (2007).. 2007 American Society of Clinical Oncology Annual Meeting, 25(18S Part I of II), (Özet bildiri) B-159-6820 STAGE I T1N0M0 BREAST CANCER BC PATHOLOGICAL CHARACTERISTICS AND CLINICAL OUTCOME , BAŞARAN GÜL,ÇABUK DEVRİM,ÇAĞLAR HALE,İYİKESİCİ MEHMET SALİH,ÇAKIR TEBESSÜM,GÜLLÜOĞLU MAHMUT BAHADIR,KAYA HANDAN,DANE FAYSAL,YUMUK PERRAN FULDEN,TURHAL NAZIM SERDAR (2006).. 31th European Society for Medical Oncology Congress, 17(suppl 9), 93-113., Doi: 10.1093/annonc/mdl206, (Özet bildiri) B-160-7816 OUTCOME OF COLON CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY IN MARMARA UNIVERSITY HOSPITAL , DANE FAYSAL,GÜMÜŞ MAHMUT,YUMUK PERRAN FULDEN,İYİKESİCİ MEHMET SALİH,ÖZTÜRK MEHMET AKİF,BAŞARAN GÜL,ÇAĞLAR HALE,ÇABUK DEVRİM,TEOMETE MEHMET,TURHAL NAZIM SERDAR (2006).. 31th European Society for Medical Oncology Congress, 17(suppl 9), 114-135., Doi: 10.1093/annonc/mdl207, (Özet bildiri) B-160-7899 OUTCOME OF PATIENTS WITH STAGE III AND IV NON SMALL CELL LUNG CANCER IN MARMARA UNIVERSITY HOSPITAL ISTANBUL TURKEY , TEOMETE MEHMET,YUMUK PERRAN FULDEN,İYİKESİCİ MEHMET SALİH,DANE FAYSAL,BAŞARAN GÜL,ÇABUK DEVRİM,ÇAĞLAR HALE,ABACIOĞLU UFUK,TURHAL NAZIM SERDAR (2006).. 31th European Society for Medical Oncology Congress, 17(suppl 9), 213-240., Doi: 10.1093/annonc/mdl216, (Özet bildiri) B-160-7731 OUTCOME OF METASTATIC COLORECTAL CANCER PATIENTS RECEIVING PALLIATIVE CHEMOTHERAPY IN MARMARA UNIVERSITY HOSPITAL , DANE FAYSAL,YUMUK PERRAN FULDEN,GÜMÜŞ MAHMUT,İYİKESİCİ MEHMET SALİH,BAŞARAN GÜL,ÇABUK DEVRİM,TEOMETE MEHMET,TURHAL NAZIM SERDAR (2006).. 31th European Society for Medical Oncology Congress, 17(suppl 9), 114-135., Doi: 10.1093/annonc/mdl207, (Özet bildiri) B-159-6782 OUTCOME OF ADJUVANT TREATMENT IN TURKISH BREAST CANCER BC PATIENTS PTS SINGLE INSTITUTION EXPERIENCE , ÇABUK DEVRİM,BAŞARAN GÜL,İYİKESİCİ MEHMET SALİH,EKENEL MELTEM,DANE FAYSAL,TEOMETE MEHMET,GÜMÜŞ MAHMUT,ALİUSTAOĞLU MEHMET,YUMUK PERRAN FULDEN,TURHAL NAZIM SERDAR (2006).. 31th European Society for Medical Oncology Congress, 17(suppl 9), 93-113., Doi: 10.1093/annonc/mdl206, (Özet bildiri) B-160-7978 Outcome of rectal carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital , DANE FAYSAL,GÜMÜŞ MAHMUT,İYİKESİCİ MEHMET SALİH,YUMUK PERRAN FULDEN,BAŞARAN GÜL,ATASOY BESTE MELEK,ABACIOĞLU UFUK,ÇABUK DEVRİM,TEOMETE MEHMET,TURHAL NAZIM SERDAR (2006).. 2006 American Society of Clinical Oncology Annual Meeting, 24(18S Part I of II), (Özet bildiri) B-160-8039 Prolonged Interval in Prophylactic Heparin Flushing for Maintenance Subcutaneous Implanted Port Care in Patients with Cancer , DANE FAYSAL,KEFELİ UMUT,YAVUZ KARAMANOĞLU AYLA,YUMUK PERRAN FULDEN,İYİKESİCİ MEHMET SALİH,BAŞARAN GÜL,TURHAL NAZIM SERDAR (2006).. Seventeenth International Congress on Anti-Cancer Treatment, (Özet bildiri) B-160-8510 Outcome of patients with stage III and IV non small cell lung cancer in Marmara University Hospital Istanbul Turkey , İYİKESİCİ MEHMET SALİH,YUMUK PERRAN FULDEN,DANE FAYSAL,EKENEL MELTEM,BAŞARAN GÜL,TURHAL NAZIM SERDAR (2005).. 11th World Conference on Lung Cancer, 49(2), (Özet bildiri) B-160-8622 The impact of body mass index in cancer a hospital based study , YUMUK PERRAN FULDEN,YUMUK VOLKAN DEMİRHAN,YAZICI DİLEK,EGE BAHADIR,BEKİROĞLU GÜLNAZ NURAL,DANE FAYSAL,İYİKESİCİ MEHMET SALİH,BAŞARAN GÜL,TURHAL NAZIM SERDAR (2005).. 14th European Congress on Obesity, 6(1), 82-82., (Özet bildiri) B-160-8181 Outcome of adjuvant treatment in elderly Turkish breast cancer patients , EKENEL MELTEM,BAŞARAN GÜL,DANE FAYSAL,İYİKESİCİ MEHMET SALİH,YUMUK PERRAN FULDEN,TURHAL NAZIM SERDAR (2005).. 2005 American Society of Clinical Oncology Annual Meeting, 23(16S Part I of II), (Özet bildiri) B-160-8111 The prognostic impact of body mass index BMI in early breast cancer BC patients pts , İYİKESİCİ MEHMET SALİH,KEFELİ UMUT,BAŞARAN GÜL,DANE FAYSAL,EKENEL MELTEM,YUMUK PERRAN FULDEN,TURHAL NAZIM SERDAR (2005).. 2005 American Society of Clinical Oncology Annual Meeting, 23(16S Part I of II), (Özet bildiri) Page: 4 B-160-8430 Outcome of elderly patients with advanced non small cell lung cancer , GÜMÜŞ MAHMUT,PALAK BANU,İYİKESİCİ MEHMET SALİH,YUMUK PERRAN FULDEN,ŞEKER MEHMET METİN,DANE FAYSAL,SALEPÇİ TAFLAN,TURHAL NAZIM SERDAR (2005).. 2005 American Society of Clinical Oncology Annual Meeting, 23(16S Part I of II), (Özet bildiri) B-160-8288 VEGF HIF 1 alpha and CD34 expressions in gastric tumors tms Relationship with pathological factors and prognostic impact on survival , ÇABUK DEVRİM,BAŞARAN GÜL,YUMUK PERRAN FULDEN,ÇELİKEL ÇİĞDEM,DANE FAYSAL,İYİKESİCİ MEHMET SALİH,EKENEL MELTEM,TURHAL NAZIM SERDAR (2005).. 2005 American Society of Clinical Oncology Annual Meeting, 23, (Özet bildiri) B-160-8147 Clinical and pathological characteristics of early breast cancer EBC patients 35 years old , BAŞARAN GÜL,DANE FAYSAL,İYİKESİCİ MEHMET SALİH,EKENEL MELTEM,YUMUK PERRAN FULDEN,TURHAL NAZIM SERDAR (2005).. 2005 American Society of Clinical Oncology Annual Meeting, 23, (Özet bildiri) B-160-9567 B-160-8969 Treatment outcomes in non small cell lung cancer NSCLC patients Comparison between Marmara University Istanbul Turkey and Knoxville Tennessee , İYİKESİCİ MEHMET SALİH,TURHAL NAZIM SERDAR,YUMUK PERRAN FULDEN,DANE FAYSAL,GÜMÜŞ MAHMUT,BAŞARAN GÜL,EKENEL MELTEM,AVERY BRUCE (2004).. European Society for Medical Oncology, 15(suppl 3), (Özet bildiri) Clinical features and adjuvant treatment outcomes of colon cancer cc in two outpatient populations of Knoxville Tennessee and Istanbul Turkey , DANE FAYSAL,TURHAL NAZIM SERDAR,İYİKESİCİ MEHMET SALİH,GÜMÜŞ MAHMUT,YUMUK PERRAN FULDEN,BAŞARAN GÜL,EKENEL MELTEM,AVERY BRUCE (2004).. European Society for Medical Oncology, 15(suppl 3), (Özet bildiri) B-160-8894 FOLFOX4 in metastatic colorectal cancer MCRC patients who progressed after infusional 5 FU Irinotecan based combination regimens , DANE FAYSAL,YUMUK PERRAN FULDEN,TURHAL NAZIM SERDAR,EKENEL MELTEM,BAŞARAN GÜL,İYİKESİCİ MEHMET SALİH,TECİMER COŞKUN (2004).. 40th American Society of Clinical Oncology Annual Meeting, 23, (Özet bildiri) B-160-8839 Adjuvant treatment outcome of high risk stage II and III colon cancer patients treated in Marmara Universtiy Istanbul , DANE FAYSAL,İYİKESİCİ MEHMET SALİH,GÜMÜŞ MAHMUT,YUMUK PERRAN FULDEN,EKENEL MELTEM,BAŞARAN GÜL,YAVUZ KARAMANOĞLU AYLA,TURHAL NAZIM SERDAR (2004).. Fifteenth International Congress on Anti-Cancer Treatment, (Özet bildiri) Education-Training Activity D-411-3552 Internal Medicine and Oncology Bachelor's Degree/Turkish (2019-2020) D-411-3542 Internal Medicine and Oncology Bachelor's Degree/Turkish (2020-2021) D-352-9883 Internal Medicine and Oncology Bachelor's Degree/Turkish (2016-2017) D-352-9882 Internal Medicine and Oncology Bachelor's Degree/Turkish D-352-9880 Internal Medicine and Oncology Bachelor's Degree/Turkish (2018-2019) References Language Turkish Turkish Turkish Turkish Turkish SSCI, SCI- Exp,AHCI Class Hours 1 1 1 1 1 Field Index AT-340-9666 Metabolically Supported Chemotherapy for Managing End Stage Breast Cancer A Complete and Durable Response (Dr.Sonrası )YAYINLAR/MAKALE/Vaka Takdimi/2021/Eser No=7226243/ 0 1 Other AT-227-7807 Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet Hyperthermia and Hyperbaric Oxygen Therapy for Stage IV Triple Negative Breast Cancer (Dr.Sonrası )YAYINLAR/MAKALE/Vaka Takdimi/2017/Eser No=6298844/ 33 23 0 0 AT-340-9672 Preliminary results of metabolically supported chemotherapy combined with ketogenic diet hyperthermia and hyperbaric oxygen therapy in stage II IV rectal cancer (Dr.Sonrası )YAYINLAR/MAKALE/Özgün Makale/2020/Eser No=6289396/ AT-227-5599 Complete Response of Locally Advanced stage III Rectal Cancer to Metabolically Supported Chemoradiotherapy with Hyperthermia (Dr.Sonrası )YAYINLAR/MAKALE/Vaka Takdimi/2016/Eser No=6289380/ AT-286-2108 Survival outcomes of metabolically supported chemotherapy combined with ketogenic diet hyperthermia and hyperbaric oxygen therapy in 0 1 0 0 6 0 5 4 1 Page: 5 Page: 6 References SSCI, SCI- Exp,AHCI Field Index Other advanced gastric cancer (Dr.Sonrası )YAYINLAR/MAKALE/Özgün Makale/2020/Eser No=6289370/ AT-227-5598 Long Term Survival Outcomes of Metabolically Supported Chemotherapy with Gemcitabine Based or FOLFIRINOX Regimen Combined with Ketogenic Diet Hyperthermia and Hyperbaric Oxygen Therapy in Metastatic Pancreatic Cancer (Dr.Sonrası )YAYINLAR/MAKALE/Özgün Makale/2020/Eser No=6289364/ AT-227-5596 Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer (Dr.Sonrası )YAYINLAR/MAKALE/Derleme Makale/2020/Eser No=6289358/ AT-227-5594 Feasibility study of metabolically supported chemotherapy with weekly carboplatin paclitaxel combined with ketogenic diet hyperthermia and hyperbaric oxygen therapy in metastatic non small cell lung cancer (Dr.Sonrası )YAYINLAR/MAKALE/Özgün Makale/2019/Eser No=6289355/ AT-227-5591 Long Term Outcomes of the Treatment of Unresectable StageIII IV Ductal Pancreatic Adenocarcinoma Using Metabolically Supported Chemotherapy MSCT A Retrospective Study (Dr.Sonrası )YAYINLAR/MAKALE/Özgün Makale/2016/Eser No=6289295/ AT-227-5590 Vascular Endothelial Growth Factor Hypoxia Inducible Factor 1 Alpha and CD34 Expressions in Early Stage Gastric Tumors Relationship with Pathological Factors and Prognostic Impact on Survival (Dr.Sonrası )YAYINLAR/MAKALE/Özgün Makale/2007/Eser No=1593739/ AT-227-5589 AT-227-5588 Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer (Dr.Sonrası )YAYINLAR/MAKALE/Özgün Makale/2009/Eser No=1587559/ AT-227-5587 Associations between clinicopathological prognostic factors and pAkt pMAPK and topoisomerase II expression in breast cancer (Dr.Sonrası )YAYINLAR/MAKALE/Özgün Makale/2014/Eser No=1587461/ Work Experience 2013 MEDICAL ONCOLOGY SPECIALIST PRIVATE BAHÇELİEVLER MEDİCAL PARK HOSPITAL 2010-2013 MEDICAL ONCOLOGY SPECIALIST PRIVATE MEDİCANA BEYLİKDÜZÜ HOSPITAL 2009-2010 MEDICAL ONCOLOGY SPECIALIST PRIVATE SİLİVRİ ANADOLU HOSPITAL 2008-2009 MEDICAL ONCOLOGY SPECIALIST DİYARBAKIR TRAINING AND RESEARCH HOSPITAL, COMPULSORY SERVICE 2006-2008 MEDICAL ONCOLOGY SPECIALIST BURSA ÇEKİRGE STATE HOSPITAL 1997-2003 INTERNAL MEDICINE SPECIALIST BURSA ÇEKİRGE STATE HOSPITAL